Reaction

Wound Infection Staphylococcal reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,719 reports · 20 co-occurring drugs

As of the last recalculation, Wound Infection Staphylococcal appears in 1,719 FAERS reports alongside 20 co-occurring drug terms. The strongest observed disproportionality signal is BASILIXIMAB (PRR 17.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Basiliximab1717.717.7
Sirolimus1513.613.6
Promethazine Hydrochloride2013.213.2
Carisoprodol1912.212.2
Standardized Senna Concentrate1211.611.6
Linezolid2711.111.1
Docusate Sodium - Sennosides2911.111.1
Meclizine Hcl 12.5Mg119.89.8
Meclizine Hcl 25Mg119.89.8
Meclizine Hcl 12.5 Mg119.89.8
Meclizine Hcl 25 Mg119.89.8
Vancomycin449.49.4
Vancomycin Hydrochloride499.29.2
Rifampin119.29.2
Interferon Beta-1A946.26.2
Methadone Hydrochloride55.65.6
Exenatide194.44.4
Conjugated Estrogens And Medroxyprogesterone Acetate73.63.6
Dalfampridine213.63.6
Glecaprevir And Pibrentasvir33.33.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.